The planet Arrakis is the central setting in the first novel of Frank Herbert's Dune series. Here's what you need to know about the location. The post Everything You Need to Know About Arrakis ...

Dune: Awakening is a massive game that might have confused players at first. Despite officially avoiding the "MMO" label, the game was commonly described as such, which may have repelled some players ...

WALTHAM, Mass.--(BUSINESS WIRE)--Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced ...

As CMON is producing Dune: War for Arrakis, the game will come with a ton of miniatures. CMON producer Thiago Aranha noted that the board would support up to 100 miniatures, many of which are ...

According to a blog post from developer Funcom to close out 2024, the death metrics for those in the closed beta show that Funcom has really nailed down the reality of a planet like Arrakis, and ...

Funcom released a new trailer this week for Dune: Awakening, as they show off more of the world of Arrakis. The look of the planet is stunning and unforgiving, but it's more than just deserts ...

The world of Arrakis is yours for the taking, if you can do it with the right resources and pieces of land in the game Risk: Dune Published Tue, 10 Dec 2024 19:12:08 -0600 ...

In desert Arrakis, temperatures would reach 70°C or more, while in its ocean state, we put the highest recorded temperatures at about 45°C. That means the ocean Arrakis would be liveable even in ...

"Dune"-inspired Arrakis Therapeutics has tested its spice—an RNA-targeting small molecule—in a mouse model of myotonic dystrophy type 1 (DM1), with the drug reversing the prolonged muscle ...

Through the agreement, Arrakis will receive an upfront payment of $190 million in cash and will have the potential to receive preclinical, clinical, commercial, and sales milestone payments and ...

Roche will pay $190 million to Arrakis upfront, along with potential preclinical, clinical, commercial and sales milestones. In aggregate, Arrakis could end up receiving several billion dollars ...

L ast year, Arrakis Therapeutics announced early but important progress toward a drug-development goal long thought to be a biotech fantasy: the creation of oral medicines that can target RNA, the ...